Furthermore, gal-7 was shown to inhibit expression of interleukin-2 and interferon-γ mRNA in Jurkat cells and was proposed as a potential new immunosuppressive therapy against inflammatory skin diseases [59]. Here, IL2 is linked to inflammatory skin disease.